You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

“Yes! We Can End TB." World TB Day is March 24, 2023. Join us in the fight.
I am a:
${ profile.name.substring(0, profile.name.length - 1) }
Request Info
Home / Tests / Critical Infectious Diseases / Xpert Xpress Flu/RSV

Xpert® Xpress Flu/RSV

Rapid detection and differentiation of Flu A, Flu B, or RSV in as soon as 20 minutes.^

Product Resources MyCepheid Store
Xpert<sup>®</sup> Xpress Flu/RSV

The Need

  • In patients of all ages, influenza and RSV often present with similar clinical symptoms, making it difficult to differentiate between the two infections1
  • Sensitivities of Rapid EIA Flu tests range from 50-70%2
  • Sensitivities of Rapid Antigen RSV tests average 29% in adults3
  • Both Rapid EIA and Antigen manufacturers suggest confirming negative results with RT-PCR or culture2
  • Rapid RSV tests may have age limitations4

(1) Falsey AR, Walsh EE. Respiratory Syncytial Virus Infection in Adults. Clin Microbiol Rev. 2000 Jul; 13.
(2) CDC. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Accessed Sep 2016. http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
(3)Chartrand C, et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015 Dec;53(12):3738-49.
(4) BD Veritor™ System – For Rapid Detection of Flu A+B. Package Insert. DB. Dublin, Ireland. 2014.

The Solution

  • Accurate and reliable detection of Flu A, Flu B and RSV in as soon as 20 minutes*
  • Enables healthcare providers to quickly deliver targeted therapies
  • Steamlines laboratory operations
  • Improves patient satisfaction

* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.

The Impact

  • Single-test confidence will accelerate your laboratory’s workflow with on-demand, random-access flexibility. Combine performance with the capability to run other Xpert® tests (including GBS, MRSA, C. difficile, CT/NG, and MTB/RIF) on Cepheid’s GeneXpert® System to achieve proven productivity increases in overall laboratory service.5-9
  • Be Proactive
  • Achieve rapid results and improve patient management
  • Early assay termination option: deliver positive results in as soon as 20 minutes* and negative results in 30 minutes
  • Quickly deliver targeted therapies and increase peace of mind for patients

* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.
^ For positive results with Flu only or RSV only reporting

(5) Morgan MG. The Perfect Storm. Cepheid Impact. 2012 Jun;2:4-7.
(6) Parada JP. Increase Revenue and Improve Patient Safety. Cepheid Impact. 2012 Jun;2:8-11.
(7) El Helali N. Less Uncertainty - Better Safety - More Healthy Newborns. Cepheid Impact. 2012 Jul;3:4-7.
(8) Haynes L. The C. difficile Challenge. Cepheid Impact. 2012 Jul;3:10-15.
(9) Parada JP. Improving Patient Safety. Cepheid Impact. 2012 Oct;4:8-11.

Ordering Info

Xpert® Xpress Flu/RSV

Number of Tests: 10

Catalog #: XPRSFLU/RSV-CE-10

Xpert® Xpress Flu/RSV

Number of Swabs: 100

Catalog #: SWAB/B-100

Xpert® Xpress Flu/RSV

Number of Swabs: 100

Catalog #: SWAB/F-100

Educational Materials

#carousel-educational-materials-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-educational-materials-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
Xpert Xpress Flu/RSV
WEBINAR

Xpert Xpress Flu/RSV

Learn how rapid PCR results from Cepheid can impact clinical decisions and support antibiotic stewardship for Influenza A, Influenza B, and RSV.

Bringing Molecular Testing Closer to the Patient&nbsp;
WEBINAR

Bringing Molecular Testing Closer to the Patient 

Speaker: Denise Geiger, PhD., DLM(ASCP)----Over the past 20 years there has been a continuous shift toward decentralization of clinical laboratory testing. With recent advances in the speed and accuracy of point-of-care tests, it is now possible to bring molecular infectious disease testing closer to the patient. This webinar will explore the benefits of molecular point-of-care testing as a means to improving patient outcomes and quality of care. Currently available testing methods will be reviewed, with an emphasis on the importance of lab testing in the era of performance-driven healthcare.

ZDoggMD discusses Flu with Cepheid CMO Dr. Dave Persing
VIDEO

ZDoggMD discusses Flu with Cepheid CMO Dr. Dave Persing

ZDoggMD and Cepheid CMO Dr. Dave Persing chat about the ever-mutating flu virus and the elements that make flu testing critical.

ZDoggMD Are you still using a flu test from the G-funk era?
VIDEO

ZDoggMD Are you still using a flu test from the G-funk era?

Addenbrooks Business Case
DOCUMENT

Addenbrooks Business Case

Point of care testing in winter Flu outbreaks
DOCUMENT

Point of care testing in winter Flu outbreaks

Article from the Clinical Services Journal

Back to Top